Andrew Fein
Stock Analyst at HC Wainwright & Co.
(2.30)
# 2,459
Out of 4,829 analysts
617
Total ratings
37.4%
Success rate
-1.83%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GPCR Structure Therapeutics | Maintains: Buy | $80 → $75 | $25.57 | +193.31% | 5 | May 12, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $72 → $68 | $27.87 | +143.99% | 5 | May 12, 2025 | |
| ALEC Alector | Maintains: Buy | $7 → $10 | $1.17 | +754.70% | 10 | May 9, 2025 | |
| PRTA Prothena Corporation | Maintains: Buy | $48 → $30 | $7.43 | +303.77% | 17 | May 9, 2025 | |
| PEPG PepGen | Maintains: Buy | $16 → $14 | $1.50 | +836.45% | 12 | May 9, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $46 → $38 | $11.41 | +233.04% | 12 | May 9, 2025 | |
| AMLX Amylyx Pharmaceuticals | Maintains: Buy | $12 → $16 | $4.61 | +247.07% | 20 | May 9, 2025 | |
| KROS Keros Therapeutics | Maintains: Buy | $40 → $25 | $13.65 | +83.15% | 15 | May 8, 2025 | |
| DNLI Denali Therapeutics | Maintains: Buy | $80 → $32 | $14.37 | +122.69% | 22 | May 7, 2025 | |
| BCRX BioCryst Pharmaceuticals | Reiterates: Buy | $30 | $9.97 | +200.90% | 10 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $301.42 | +41.00% | 15 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $16 | $9.83 | +62.77% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $241 → $187 | $118.17 | +58.25% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $81 → $24 | $6.61 | +263.09% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $135 | $97.17 | +38.93% | 18 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $12 | $1.68 | +614.29% | 16 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $38 | $22.77 | +66.89% | 6 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $2.07 | +286.47% | 2 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $185 → $168 | $115.71 | +45.19% | 20 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $90 | $65.08 | +38.29% | 14 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $0.88 | +695.45% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $0.98 | +1,022.33% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $2.86 | +109.79% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.23 | +713.01% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $6.59 | +234.09% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $15.26 | +90.04% | 12 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $9.36 | +402.14% | 13 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $0.87 | +129.49% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $2.46 | +469.11% | 13 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $11.90 | +68.14% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.61 | +647.66% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.20 | +209.52% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.88 | +59.88% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.24 | +609.88% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.27 | +1,081.10% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $40.90 | +107.82% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $23.37 | +49.76% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $60 | $30.07 | +99.53% | 7 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $17.44 | +54.82% | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $5.36 | -25.37% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.45 | +1,062.79% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $550 | $424.99 | +29.41% | 26 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $23.74 | +215.92% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.60 | +1,775.00% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.91 | +775.18% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.47 | +376.19% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.20 | +61.29% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.05 | +1,855.99% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.71 | +21,176.60% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $10.38 | +478.03% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $2.19 | +584.93% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.60 | +2,400.00% | 3 | Mar 16, 2022 |
Structure Therapeutics
May 12, 2025
Maintains: Buy
Price Target: $80 → $75
Current: $25.57
Upside: +193.31%
Avidity Biosciences
May 12, 2025
Maintains: Buy
Price Target: $72 → $68
Current: $27.87
Upside: +143.99%
Alector
May 9, 2025
Maintains: Buy
Price Target: $7 → $10
Current: $1.17
Upside: +754.70%
Prothena Corporation
May 9, 2025
Maintains: Buy
Price Target: $48 → $30
Current: $7.43
Upside: +303.77%
PepGen
May 9, 2025
Maintains: Buy
Price Target: $16 → $14
Current: $1.50
Upside: +836.45%
Dyne Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $46 → $38
Current: $11.41
Upside: +233.04%
Amylyx Pharmaceuticals
May 9, 2025
Maintains: Buy
Price Target: $12 → $16
Current: $4.61
Upside: +247.07%
Keros Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $40 → $25
Current: $13.65
Upside: +83.15%
Denali Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $80 → $32
Current: $14.37
Upside: +122.69%
BioCryst Pharmaceuticals
May 6, 2025
Reiterates: Buy
Price Target: $30
Current: $9.97
Upside: +200.90%
May 5, 2025
Reiterates: Buy
Price Target: $425
Current: $301.42
Upside: +41.00%
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $9.83
Upside: +62.77%
May 2, 2025
Maintains: Buy
Price Target: $241 → $187
Current: $118.17
Upside: +58.25%
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $6.61
Upside: +263.09%
May 2, 2025
Reiterates: Buy
Price Target: $135
Current: $97.17
Upside: +38.93%
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $1.68
Upside: +614.29%
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $22.77
Upside: +66.89%
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.07
Upside: +286.47%
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $115.71
Upside: +45.19%
Apr 22, 2025
Reiterates: Buy
Price Target: $90
Current: $65.08
Upside: +38.29%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $0.88
Upside: +695.45%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $0.98
Upside: +1,022.33%
Mar 28, 2025
Reiterates: Buy
Price Target: $6
Current: $2.86
Upside: +109.79%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.23
Upside: +713.01%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $6.59
Upside: +234.09%
Mar 20, 2025
Reiterates: Buy
Price Target: $29
Current: $15.26
Upside: +90.04%
Mar 19, 2025
Reiterates: Buy
Price Target: $47
Current: $9.36
Upside: +402.14%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $0.87
Upside: +129.49%
Mar 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.46
Upside: +469.11%
Mar 14, 2025
Reiterates: Buy
Price Target: $20
Current: $11.90
Upside: +68.14%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.61
Upside: +647.66%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.20
Upside: +209.52%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $6.88
Upside: +59.88%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.24
Upside: +609.88%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.27
Upside: +1,081.10%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $40.90
Upside: +107.82%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $23.37
Upside: +49.76%
Feb 28, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $30.07
Upside: +99.53%
Feb 27, 2025
Reiterates: Buy
Price Target: $27
Current: $17.44
Upside: +54.82%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $5.36
Upside: -25.37%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $6.45
Upside: +1,062.79%
Feb 11, 2025
Reiterates: Buy
Price Target: $550
Current: $424.99
Upside: +29.41%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $23.74
Upside: +215.92%
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $1.60
Upside: +1,775.00%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $0.91
Upside: +775.18%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.47
Upside: +376.19%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.20
Upside: +61.29%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.05
Upside: +1,855.99%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.71
Upside: +21,176.60%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $10.38
Upside: +478.03%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $2.19
Upside: +584.93%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.60
Upside: +2,400.00%